 Progyny Inc NASDAQ:PGNY announced that shipments of its fertility medication Menopur have resumed following an industry wide shortage, prompting the company to boost its fourth quarter and full year guidance. During the companys earnings call on November 3, executives said that the assumption was that Menopur would not be available for the remainder of 2022. 